Approval · Notice of Compliance 20748 · 2018
PROBUPHINE: Notice of Compliance 20748
Issued April 18, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20748
- Date
- April 18, 2018
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROBUPHINE | 02474921 | Cancelled Post Market |
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 80 MG per IMP